KLF15 and myocarditis: We observed that I3C (20 mg/kg) pre-treatment for a month alleviated myocardial inflammation by inhibiting WWP1 activity, manifested by up-regulated protein level of KLF15 and obviously suppressed inflammatory signaling pathways.